Australia
Nanollose Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.
Anatara Lifesciences is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company’s cash position at the end of the quarter stood at $7.1m.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Regeneus Ltd provides the Company’s quarterly results for the period ended 30 September 2018.
Anatara Lifesciences to announce the formation of its Product Development Advisory Board.
Oventus Medical Ltd is pleased to announce that new clinical data from four separate studies on its Sleep Treatment Platform will be presented at Sleep DownUnder, the 30th annual meeting of sleep specialists, taking place in Brisbane between 17th -20th October.
Regeneus Ltd is pleased to announce it has received a Notice of Intention to Grant a European patent covering the use of Progenza by the European Patent Office.
WA Primary Health Alliance (WAPHA) has recently implemented HappyOrNot, the smiley face customer satisfaction service, in selected general practices in Western Australia, giving patients a simple way to provide immediate feedback on a visit to their local GP.
Anatara Lifesciences is pleased to release its Annual Report, for the year ended 30th June 2018.
PRESS RELEASES